Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment

Neuropsychopharmacology

Volumn 34, Issue 13, 2009, Pages 2710-2720

  Alexander, Kathleen S ^a   Brooks, Julie M ^a   Sarter, Martin ^b   Bruno, John P ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acetylcholine; Clozapine; Hippocampus; Nucleus accumbens; Prefrontal cortex; Schizophrenia

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; CLOZAPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ACETYLCHOLINE RELEASE; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DISEASE MODEL; EVOKED RESPONSE; HIPPOCAMPUS; LIMBIC CORTEX; LOW DRUG DOSE; MALE; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREPUBERTY; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ACETYLCHOLINE; AGING; AMPHETAMINE; ANIMALS; ANIMALS, NEWBORN; CLOZAPINE; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IBOTENIC ACID; MALE; MICROINJECTIONS; N-METHYLASPARTATE; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SCHIZOPHRENIA; TIME FACTORS;

EID: 70449531474     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.105     Document Type: Article

References (66)

1. Arnold HM, Nelson CL, Neigh GH, Sarter M, Bruno JP (2000). Systemic and intra-accumbens administration of amphetamine differentially affects cortical acetylcholine release. Neuroscience 96: 675-685.
2. Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M et al. (2009). Selecting paradigms from cognitive neuro-science for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull 35: 109-114.
3. Bhardwaj SK, Beaudry G, Quirion R, Levesque D, Srivastava LK (2003). Neonatal ventral hippocampus lesion leads to reductions in nerve growth factor inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum. Neuroscience 122: 669-676.
4. Brady AM, O'Donnell P (2004). Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo. J Neurosci 24: 1040-1049.
5. Braff DL, Light GA (2004). Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacol-ogy (Berl) 174: 75-85.
6. Brooks JM, Sarter M, Bruno JP (2007). D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex. Neuropharmacology 53: 455-463.
7. Chambers RA, Moore J, McEvoy JP, Levin ED (1996). Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 15: 587-594.
8. El-Rawas R, Saadé NE, Thiriet N, Atweh S, Jaber M, Al-Amin HA (2009). Developmental changes in the mRNA expression of neuropeptides and dopamine and glutamate receptors in neonates and adult rats after hippocampal lesion. Schizophr Res [E-pub ahead of print].
9. Flores G, Alquicer G, Silva-Gómez AB, Zaldivar G, Stewart J, Quirion R et al. (2005). Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133: 463-470.
10. Gaykema RP, Zaborszky L (1996). Direct catecholaminergic-cholinergic interactions in the basal forebrain II. Substantia nigra-ventral tegmental area projections to cholinergic neurons. J Comp Neurol 374: 555-577. (Pubitemid 26359445)
11. Goto Y, O'Donnell P (2002). Delayed mesolimbic system alteration in a developmental animal model of schizophrenia. J Neurosci 22: 9070-9077.
12. Goto Y, O'Donnell P (2004). Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia. Biol Psychiatry 55: 172-176.
13. Grace AA (2000). Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 31: 330-341.
14. Groenewegen HJ, Vermeulenvanderzee E, Kortschot AT, Witter MP (1987). Organization of the projections from the subiculum to the ventral striatum in the ratFa study using anterograde transport of phaseolus-vulgaris leukoagglutinin. Neuroscience 23: 103-120.
15. Gruber AJ, O'Donnell P (2009). Bursting activation of prefrontal cortex drives sustained up states in nucleus accumbens spiny neurons in vivo. Synapse 63: 173-180.
16. Hagan JJ, Jones DN (2005). Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr Bull 31: 830-853.
17. Henny P, Jones BE (2008). Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and gluta-matergic inputs to pyramidal cells or interneurons. Eur J Neurosci 27: 654-670.
18. Himmelheber AM, Sarter M, Bruno JP (2000). Increases in cortical acetylcholine release during sustained attention performance in rats. Cogn Brain Res 9: 313-325.
19. Huang T, Yang L, Gitzen J, Kissinger PT, Vreeke M, Heller A (1995). Detection of basal acetylcholine in rat brain micro-dialysates. J Chromatogr 670: 323-327.
20. Hyde TM, Crook JM (2001). Cholinergic systems and schizophrenia: primary pathology or epiphenomena? J Chem Neuroa-nat 22: 53-63.
21. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002). Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26: 325-339.
22. Ingham CA, Bolam JP, Smith AD (1988). GABA-immunoreactive synaptic boutons in the rat basal forebrain: comparison of neurons that project to the neocortex with pallidosubthalamic neurons. J Comp Neurol 273: 263-282.
23. Kapur S, VanderSpek SC, Brownlee BA, Nobrega JN (2003). Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305: 625-631.
24. Kerns JG, Neuchterlein KH, Braver TS, Barch DM (2008). Executive functioning component mechanisms and schizophrenia. Biol Psychiatry 64: 26-33.
25. Kozak R, Martinez V, Young D, Brown H, Bruno JP, Sarter M (2007). Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology 32: 2074-2086.
26. Kozak R, Bruno JP, Sarter M (2006). Augmented prefrontal acetylcholine release during challeneged attentional performance. Cereb Cortex 16: 917.
27. Kozak R, Martinez V, Young D, Brown H, Bruno JP, Sarter M (2007). Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology 32: 2074-2086.
28. LaPlante F, Srivastava LK, Quirion R (2004). Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. J Neurochem 89: 314-323. (Pubitemid 38495980)
29. Le Pen G, Grottick AJ, Higgins GA, Moreau JL (2003). Phencyclidine exacerbates attentional deficits in a neurodeve-lopmental rat model of schizophrenia. Neuropsychopharmacol-ogy 28: 1799-1809.
30. Le Pen G, Grottick AJ, Higgins GA, Martin JR, Jenck F, Moreau JL (2000). Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia. Behav Pharmacol 11: 257-268.
31. Lewis BL, O'Donnell P (2000). Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors. Cereb Cortex 10: 1168-1175.
32. Li Z, Huang M, Ichikawa J, Dai J, Meltzer HY (2005). N- desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors. Neuropsychopharmacology 30: 1986-1995.
33. Lipska BK, Jaskiw GE, Weinberger DR (1993). Postpubertal emergence of hyperresponsiveness to stress and amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9: 67-75.
34. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. (1995). Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122: 35-43.
35. Lipska BK, Lerman DN, Khaing ZZ, Weickert CS, Weinberger DR (2003). Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J Neurosci 18: 391-402.
36. Marquis JP, Goulet S, Dore FY (2008). Neonatal ventral hippocampus lesions disrupt extra-dimensional shift and alter dendritic spine density in the medial prefrontal cortex of juvenile rats. Neurobiol Learn Mem 90: 339-346.
37. Martin G, Siggins GR (2002). Electrophysiological evidence for expression of glycine receptors in freshly isolated neurons from nucleus accumbens. J Pharmacol Exp Ther 302: 1135-1145.
38. Martinez V, Sarter M (2008). Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia. Neuropsychopharmacology 33: 2635-2647.
39. McGaughy J, Dalley JW, Morison CH, Everitt BJ, Robbins TW (2002). Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 22: 1905-1913.
40. McGaughy J, Kaiser T, Sarter M (1996). Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav Neurosci 110: 247-265.
41. Mishara AL, Goldberg TE (2004). A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol Psychiatry 55: 1013-1022.
42. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK (2004). Identification of separable cognitive factors in schizophrenia. Schizophr Res 72: 29-39.
43. Nuechterlein KH, Dawson ME (1984). Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 10: 160-203.
44. Nuechterlein KH, Luck SJ, Lustig C, Sarter M (2009). CNTRICS final task selection: control of attention. Schizophr Bull 35: 182-196.
45. O'Donnell P, Grace AA (1995). Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 15: 3622-3639.
46. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK (2002). Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex 12: 975-982.
47. Potter PE, Meek JL, Neff NH (1983). Acetylcholine and choline in neuronal tissue measured by HPLC with electrochemical detection. J Neurochem 41: 188-194.
48. Raedler TJ, Knable MB, Jones DW, Urbina RA, Gorey JG, Lee KS et al. (2003). In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am J Psychiatry 160: 118-127.
49. Rueter LE, Ballard ME, Gallagher KB, Basso AM, Curzon P, Kohlhaas KL (2004). Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psycho-pharmacology (Berl) 176: 312-319.
50. Sarter M, Gehring WJ, Kozak R (2006). More attention must be paid: the neurobiology of attentional effort. Brain Res Rev 51: 145-160.
51. Sarter M, Hasselmo ME, Bruno JP, Givens B (2005a). Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Rev 48: 98111.
52. Sarter M, Martinez V, Kozak R (2009). A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology (Berl) 202: 237-258.
53. Sarter M, Nelson CL, Bruno JP (2005b). Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophr Bull 31: 117-138.
54. St Peters M, Bruno J.P, Sarter M (2009). Accumbens NMDA Receptor Stimulation Enhances Attentional Performance as a Function of Demands on Top-Down Control. Society for Neuroscience Annual Meeting: Chicago, IL.
55. Tseng KY, Amin F, Lewis BL, O'Donnell P (2006). Altered prefrontal cortical metabolic response to mesocortical activation in adult animals with a neonatal ventral hippocampal lesion. Biol Psychiatry 60: 585-590.
56. Tseng KY, Lewis BL, Hashimoto T, Sesack SR, Kloc M, Lewis DA et al. (2008). A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J Neurosci 28: 12691-12699.
57. Tseng KY, Lewis BL, Lipska BK, O'Donnell P (2007). Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia. Biol Psychiatry 62: 730-738.
58. Usuda I, Tanaka K, Chiba T (1998). Efferent projections of the nucleus accumbens in the rat with special reference to subdivision of the nucleus: biotinylated dextran amine study. Brain Res 797: 73-93.
59. Vasey MW, Thayer JF (1987). The continuing problem of false positives in repeated measures ANOVA in psychophysiologyFa multivariate solution. Psychophysiology 24: 479-489.
60. Wescott S, Gritton H, Parikh V, Bruno JP, Sarter M (2009). Nicotine-evoked recruitment of prefrontal, signal detection-mediating mechanisms, are abolished in the neonatal ventral hippocampal lesion model of schizophrenia. Society for Neuro-science Annual Meeting: Chicago, IL.
61. Yim CY, Mogenson GJ (1982). Response of nucleus accumbens neurons to amygdala stimulation and its modification by dopamine. Brain Res 239: 401-415.
62. Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA (2009). Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122: 150-202.
63. Zaborszky L, Cullinan WE (1992). Projections from the nucleus accumbens to cholinergic neurons of the ventral pallidum: a correlated light and electron microscopic double-immunolabel-ing study in rat. Brain Res 570: 92101.
64. Zaborszky L, Pang K, Somogyi J, Nadasdy Z, Kallo I (1999). The basal forebrain corticopetal system revisited. Ann N Y Acad Sci 877: 339-367.
65. Zmarowski A, Sarter M, Bruno JP (2005). NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release. Eur J Neurosci 22: 1731-1740.
66. Zmarowski A, Sarter M, Bruno JP (2007). Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release. Synapse 61: 115-123.